Cassava Sciences, Inc.
(NASDAQ : SAVA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICLRICON plc -1.09%249.202.8%$140.36m
VRXValeant Pharmaceuticals International, Inc. -4.83%23.8514.1%$140.34m
HZNPHorizon Therapeutics Plc -1.06%85.515.4%$112.65m
BHCBausch Health Cos., Inc. -4.83%23.850.0%$102.65m
CTLTCatalent, Inc. -5.40%96.572.0%$101.90m
JAZZJazz Pharmaceuticals Plc -3.75%131.632.1%$84.31m
SAVACassava Sciences, Inc. -3.72%34.980.0%$82.37m
UTHRUnited Therapeutics Corp. -0.84%198.3813.9%$78.21m
ZGNXZogenix, Inc. -0.12%25.957.5%$77.82m
PRGOPerrigo Co. Plc -4.53%37.086.9%$46.99m
ARGXargenx SE -5.26%264.560.0%$45.87m
PCRXPacira Biosciences, Inc. -2.54%61.829.8%$27.95m
BRBRBellRing Brands, Inc. 1.97%24.900.0%$26.69m
IRWDIronwood Pharmaceuticals, Inc. -0.05%10.999.5%$22.81m
SAGESAGE Therapeutics, Inc. -3.40%36.917.6%$17.30m

Company Profile

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.